New York State Common Retirement Fund
AEGR

New York State Common Retirement Fund’s Aegerion Pharmaceuticals AEGR Stock Holding History

New York State Common Retirement Fund’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,800
Closed -$15K – 3193
2016
Q2 		$15K Sell
9,800
-14,800
-60% -$33.9K ﹤0.01% 3157
2016
Q1 		$91K Hold
24,600
– – ﹤0.01% 2947
2015
Q4 		$248K Sell
24,600
-6,760
-22% -$81.4K ﹤0.01% 2657
2015
Q3 		$426K Sell
31,360
-4,644
-13% -$82.7K ﹤0.01% 2388
2015
Q2 		$683K Buy
36,004
+22,544
+167% +$488K ﹤0.01% 2388
2015
Q1 		$352K Buy
+13,460
New +$343K ﹤0.01% 2086
2014
Q4 		– Sell
-37,213
Closed -$1.24M – 2088
2014
Q3 		$1.24M Buy
+37,213
New +$1.15M ﹤0.01% 1800

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

New York State Common Retirement Fund's AEGR Position: Q3 2016 in Review

New York State Common Retirement Fund sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2016, closing a stake of 9,800 shares — an estimated $15K sold.

New York State Common Retirement Fund first reported a position in AEGR in Q3 2014 and held it in 7 quarters. The position peaked at $1.24M in Q3 2014. 58 funds tracked by Wall St. Rank hold AEGR as of Q3 2016.

  • New York State Common Retirement Fund reported no remaining Aegerion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • New York State Common Retirement Fund sold 9,800 Aegerion Pharmaceuticals shares in Q3 2016, an estimated $15K.
  • New York State Common Retirement Fund first reported a position in Aegerion Pharmaceuticals in Q3 2014 and held it in 7 quarters.
  • New York State Common Retirement Fund's Aegerion Pharmaceuticals position peaked at $1.24M in Q3 2014.
  • 58 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2016.

Based on New York State Common Retirement Fund's 13F filing for Q3 2016, filed 8 Nov 2016.